MCRPC

Clinical trials for MCRPC explained in plain language.

Never miss a new study

Get alerted when new MCRPC trials appear

Sign up with your email to follow new studies for MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New drug combo tested for Tough-to-Treat prostate cancer

Disease control Not yet recruiting

This early study is testing the safety and initial effectiveness of a new oral drug called LC-K76 when given alongside an immunotherapy drug (Tislelizumab) in men with advanced prostate cancer that has spread to the bones and is no longer responding to standard hormone therapies …

Matched conditions: MCRPC

Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

MCRPC

Get alerted when new MCRPC trials appear

New drug combo tested for Tough-to-Treat prostate cancer